Dr. Viviane Tabar was quoted in an NPR story about the possible return of Brain Cell Transplants… for Parkinson’s patients.  Over a decade ago research was conducted to transplant fetal brain cells into Parkinson’s patients, with the goal of helping replace lost dopamine producing cells. Those early studies were halted due to adverse effects and lack of significant improvements. However, Dr. Tabar and colleagues never stopped working.  And today, with colleagues at MSK an, she is hoping to get FDA approval to begin trials of treating Parkinson’s patients with laboratory-created pure dopamine cells in 2018. Tabar is hopeful that this new treatment is exactly the innovation that Parkinson’s research needs. “On the one hand, you don’t want to rush,” she says. “On the other hand I think the field is ready for something bold.”